Investopedia: Pricing Still A Long-Term Risk, But Illumina Continues To Build A Sequencing Fortress

Between the disruptions created by Thermo Fisher 's (NYSE: TMO ) acquisition of Life Technologies, Roche (Nasdaq: RHHBY ) all but raisi...